SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    World Health Organization. The world health report 2004 - changing history. Geneva: World Health Organization; 2004. p. 130.
  • 2
    National Center for Health Statistics. Health, United States, 2005 - with chartbook on trends in the health of Americans. Hyattsville, MD: National Center for Health Statistics; 2005. p. 183.
  • 3
    Tzanakakis ES, Hess DJ, Sielaff TD, Hu WS. Extracorporeal tissue engineered liver-assist devices. Annu Rev Biomed Eng 2000; 2: 607632.
  • 4
    van de Kerkhove MP, Hoekstra R, Chamuleau RA, van Gulik TM. Clinical application of bioartificial liver support systems. Ann Surg 2004; 240: 216230.
  • 5
    Tsiaoussis J, Newsome PN, Nelson LJ, Hayes PC, Plevris JN. Which hepatocyte will it be? Hepatocyte choice for bioartificial liver support systems. Liver Transpl 2001; 7: 210.
  • 6
    Hoekstra R, Chamuleau RA. Recent developments on human cell lines for the bioartificial liver. Int J Artif Organs 2002; 25: 182191.
  • 7
    Gerlach JC, Zeilinger K, Sauer IM, Mieder T, Naumann G, Grunwald A, et al. Extracorporeal liver support: porcine or human cell based systems? Int J Artif Organs 2002; 25: 10131018.
  • 8
    Morsiani E, Brogli M, Galavotti D, Pazzi P, Puviani AC, Azzena GF. Biologic liver support: optimal cell source and mass. Int J Artif Organs 2002; 25: 985993.
  • 9
    Chan C, Berthiaume F, Nath BD, Tilles AW, Toner M, Yarmush ML. Hepatic tissue engineering for adjunct and temporary liver support: critical technologies. Liver Transpl 2004; 10: 13311342.
  • 10
    Chamuleau RA, Deurholt T, Hoekstra R. Which are the right cells to be used in a bioartificial liver? Metab Brain Dis 2005; 20: 327335.
  • 11
    Patience C, Takeuchi Y, Weiss RA. Infection of human cells by an endogenous retrovirus of pigs. Nat Med 1997; 3: 282286.
  • 12
    Baccarani U, Sanna A, Cariani A, Sainz-Barriga M, Adani GL, Zambito AM, et al. Isolation of human hepatocytes from livers rejected for liver transplantation on a national basis: results of a 2-year experience. Liver Transpl 2003; 9: 506512.
  • 13
    Sauer IM, Zeilinger K, Pless G, Kardassis D, Theruvath T, Pascher A, et al. Extracorporeal liver support based on primary human liver cells and albumin dialysis–treatment of a patient with primary graft non-function. J Hepatol 2003; 39: 649653.
  • 14
    Deurholt T, Ten Bloemendaal L, Chatta AA, van Wijk AC, Weijer K, Seppen J, et al. In vitro functionality of human fetal liver cells and clonal derivatives under proliferative conditions. Cell Transplant 2006; 15: 811822.
  • 15
    Hamamoto R, Kamihira M, Iijima S. Growth and differentiation of cultured fetal hepatocytes isolated various developmental stages. Biosci Biotechnol Biochem 1999; 63: 395401.
  • 16
    Flendrig LM, la Soe JW, Jorning GG, Steenbeek A, Karlsen OT, Bovee WM, et al. In vitro evaluation of a novel bioreactor based on an integral oxygenator and a spirally wound nonwoven polyester matrix for hepatocyte culture as small aggregates. J Hepatol 1997; 26: 13791392.
  • 17
    Flendrig LM, Chamuleau RA, Maas MA, Daalhuisen J, Hasset B, Kilty CG, et al. Evaluation of a novel bioartificial liver in rats with complete liver ischemia: treatment efficacy and species-specific alpha-GST detection to monitor hepatocyte viability. J Hepatol 1999; 30: 311320.
  • 18
    van de Kerkhove MP, Di Florio E, Scuderi V, Mancini A, Belli A, Bracco A, et al. Phase I clinical trial with the AMC-bioartificial liver. Academic Medical Center. Int J Artif Organs 2002; 25: 950959.
  • 19
    Poyck PP, Hoekstra R, van Wijk AC, Ten Bloemendaal L, Chamuleau RA, van Gulik TM. Mild hypothermic preservation for transport purposes of the AMC bioartificial liver charged with porcine hepatocytes. Transplantation 2005; 80: 11531160.
  • 20
    Seglen PO. Preparation of rat liver cells. 3. Enzymatic requirements for tissue dispersion. Exp Cell Res 1973; 82: 391398.
  • 21
    van de Kerkhove MP, Poyck PPC, van Wijk ACWA, Galavotti D, Hoekstra R, van Gulik TM, et al. Assessment and improvement of liver specific function of the AMC-bioartificial liver. Int J Artif Organs 2005; 28: 617630.
  • 22
    Hoekstra R, Deurholt T, ten Bloemendaal L, Desille M, van Wijk AC, Clement B, et al. Assessment of reversion of immortalisation and in vitro functionality of NKNT-3 cells and clonal derivatives. Cell Transplant 2006; 15: 423433.
  • 23
    Jauregui HO, Hayner NT, Driscoll JL, Williams-Holland R, Lipsky MH, Galletti PM. Trypan blue dye uptake and lactate dehydrogenase in adult rat hepatocytes–freshly isolated cells, cell suspensions, and primary monolayer cultures. In Vitro 1981; 17: 11001110.
  • 24
    O'Brien PJ, Chan K, Silber PM. Human and animal hepatocytes in vitro with extrapolation in vivo. Chem Biol Interact 2004; 150: 97114.
  • 25
    Jorjani P, Ozturk SS. Effects of cell density and temperature on oxygen consumption rate for different mammalian cell lines. Biotechnol Bioeng 1999; 64: 349356.
  • 26
    Poyck PP, Pless G, Hoekstra R, Roth S, van Wijk ACWA, Schwartlander R, et al. In vitro comparison of two bioartificial liver support systems: MELS CellModule and AMC-BAL. Int J Artif Organs (in press).
  • 27
    Werner A, Duvar S, Muthing J, Buntemeyer H, Lunsdorf H, Strauss M, et al. Cultivation of immortalized human hepatocytes HepZ on macroporous CultiSpher G microcarriers. Biotechnol Bioeng 2000; 68: 5970.
  • 28
    Wang L, Sun J, Li L, Mears D, Horvat M, Sheil AG. Comparison of porcine hepatocytes with human hepatoma (C3A) cells for use in a bioartificial liver support system. Cell Transplant 1998; 7: 459468.
  • 29
    Nagaki M, Miki K, Kim YI, Ishiyama H, Hirahara I, Takahashi H, et al. Development and characterization of a hybrid bioartificial liver using primary hepatocytes entrapped in a basement membrane matrix. Dig Dis Sci 2001; 46: 10461056.
  • 30
    Yamashita Y, Shimada M, Tsujita E, Shirabe K, Ijima H, Nakazawa K, et al. High metabolic function of primary human and porcine hepatocytes in a polyurethane foam/spheroid culture system in plasma from patients with fulminant hepatic failure. Cell Transplant 2002; 11: 379384.
  • 31
    Vijayalakshmi V, Naseem B, Khan AA, Capoor AK, Habibullah CM. Comparison of biochemical and cytotoxic functions of hepatocytes from goat, pig and human fetuses. J Gastroenterol Hepatol 2004; 19: 10291035.
  • 32
    Watford M. Hepatic glutaminase expression: relationship to kidney-type glutaminase and to the urea cycle. FASEB J 1993; 7: 14681474.
  • 33
    Curthoys NP, Watford M. Regulation of glutaminase activity and glutamine metabolism. Annu Rev Nutr 1995; 15: 133159.
  • 34
    Meijer AJ. Channeling of ammonia from glutaminase to carbamoyl-phosphate synthetase in liver mitochondria. FEBS Lett 1985; 191: 249251.
  • 35
    Meijer AJ, Lamers WH, Chamuleau RA. Nitrogen metabolism and ornithine cycle function. Physiol Rev 1990; 70: 701748.
  • 36
    Bogaards JJ, Bertrand M, Jackson P, Oudshoorn MJ, Weaver RJ, van Bladeren PJ, et al. Determining the best animal model for human cytochrome P450 activities: a comparison of mouse, rat, rabbit, dog, micropig, monkey and man. Xenobiotica 2000; 30: 11311152.
  • 37
    Zuber R, Anzenbacherova E, Anzenbacher P. Cytochromes P450 and experimental models of drug metabolism. J Cell Mol Med 2002; 6: 189198.
  • 38
    Maurel P. The use of adult human hepatocytes in primary culture and other in vitro systems to investigate drug metabolism in man. Adv Drug Deliv Rev 1996; 22: 105132.
  • 39
    Guengerich FP. Comparisons of catalytic selectivity of cytochrome P450 subfamily enzymes from different species. Chem Biol Interact 1997; 106: 161182.
  • 40
    Stevens JC, Hines RN, Gu C, Koukouritaki SB, Manro JR, Tandler PJ, et al. Developmental expression of the major human hepatic CYP3A enzymes. J Pharmacol Exp Ther 2003; 307: 573582.
  • 41
    Williams JA, Ring BJ, Cantrell VE, Jones DR, Eckstein J, Ruterbories K, et al. Comparative metabolic capabilities of CYP3A4, CYP3A5, and CYP3A7. Drug Metab Dispos 2002; 30: 883891.
  • 42
    Jasmund I, Schwientek S, Acikgoz A, Langsch A, Machens HG, Bader A. The influence of medium composition and matrix on long-term cultivation of primary porcine and human hepatocytes. Biomol Eng 2007; 24: 5969.
  • 43
    Hino H, Tateno C, Sato H, Yamasaki C, Katayama S, Kohashi T, et al. A long-term culture of human hepatocytes which show a high growth potential and express their differentiated phenotypes. Biochem Biophys Res Commun 1999; 256: 184191.
  • 44
    Pahernik SA, Thasler WE, Mueller-Hoecker J, Schildberg FW, Koebe HG. Hypothermic storage of pig hepatocytes: influence of different storage solutions and cell density. Cryobiology 1996; 33: 552566.
  • 45
    Nyberg SL, Remmel RP, Mann HJ, Peshwa MV, Hu WS, Cerra FB. Primary hepatocytes outperform Hep G2 cells as the source of biotransformation functions in a bioartificial liver. Ann Surg 1994; 220: 5967.
  • 46
    De Bartolo L, Jarosch-Von Schweder G, Haverich A, Bader A. A novel full-scale flat membrane bioreactor utilizing porcine hepatocytes: cell viability and tissue-specific functions. Biotechnol Prog 2000; 16: 102108.
  • 47
    Nyberg SL, Hardin J, Amiot B, Argikar UA, Remmel RP, Rinaldo P. Rapid, large-scale formation of porcine hepatocyte spheroids in a novel spheroid reservoir bioartificial liver. Liver Transpl 2005; 11: 901910.
  • 48
    Shito M, Kim NH, Baskaran H, Tilles AW, Tompkins RG, Yarmush ML, et al. In vitro and in vivo evaluation of albumin synthesis rate of porcine hepatocytes in a flat-plate bioreactor. Artif Organs 2001; 25: 571578.
  • 49
    Lescoat G, Theze N, Fraslin JM, Pasdeloup N, Kneip B, Guguen-Guillouzo C. Influence of ornithine on albumin synthesis by fetal and neonatal hepatocytes maintained in culture. Cell Differ 1987; 21: 2129.
  • 50
    Guguen-Guillouzo C, Clement B, Lescoat G, Glaise D, Guillouzo A. Modulation of human fetal hepatocyte survival and differentiation by interactions with a rat liver epithelial cell line. Dev Biol 1984; 105: 211220.
  • 51
    Lazaro CA, Croager EJ, Mitchell C, Campbell JS, Yu C, Foraker J, et al. Establishment, characterization, and long-term maintenance of cultures of human fetal hepatocytes. Hepatology 2003; 38: 10951106.
  • 52
    Kimura K, Jung BD, Kanehira K, Irie Y, Canas X, Saito M. Induction of uncoupling protein (UCP) 2 in primary cultured hepatocytes. FEBS Lett 1999; 457: 7579.
  • 53
    Cheng G, Polito CC, Haines JK, Shafizadeh SF, Fiorini RN, Zhou X, et al. Decrease of intracellular ATP content downregulated UCP2 expression in mouse hepatocytes. Biochem Biophys Res Commun 2003; 308: 573580.
  • 54
    Agius L. Metabolic interactions of parenchymal hepatocytes and dividing epithelial cells in co-culture. Biochem J 1988; 252: 2328.
  • 55
    Lazar A, Peshwa MV, Wu FJ, Chi CM, Cerra FB, Hu WS. Formation of porcine hepatocyte spheroids for use in a bioartificial liver. Cell Transplant 1995; 4: 259268.
  • 56
    Sakai Y, Naruse K, Nagashima I, Muto T, Suzuki M. A new bioartificial liver using porcine hepatocyte spheroids in high-cell-density suspension perfusion culture: in vitro performance in synthesized culture medium and in 100% human plasma. Cell Transplant 1999; 8: 531541.
  • 57
    Iacovacci S, Manzin A, Barca S, Sargiacomo M, Serafino A, Valli MB, et al. Molecular characterization and dynamics of hepatitis C virus replication in human fetal hepatocytes infected in vitro. Hepatology 1997; 26: 13281337.
  • 58
    Ochiya T, Tsurimoto T, Ueda K, Okubo K, Shiozawa M, Matsubara K. An in vitro system for infection with hepatitis B virus that uses primary human fetal hepatocytes. Proc Natl Acad Sci USA 1989; 86: 18751879.